Literature DB >> 16260042

Rapid identification of 14-3-3-binding proteins by protein microarray analysis.

Jun-ichi Satoh1, Yusuke Nanri, Takashi Yamamura.   

Abstract

The 14-3-3 protein family consists of acidic 30-kDa proteins composed of seven isoforms in mammalian cells, expressed abundantly in neurons and glial cells of the central nervous system (CNS). The 14-3-3 isoforms form a dimer that acts as a molecular adaptor interacting with key signaling components involved in cell proliferation, transformation, and apoptosis. Until present, more than 300 proteins have been identified as 14-3-3-binding partners, although most of previous studies focused on a limited range of 14-3-3-interacting proteins. Here, we studied a comprehensive profile of 14-3-3-binding proteins by analyzing a high-density protein microarray using recombinant human 14-3-3 epsilon protein as a probe. Among 1752 proteins immobilized on the microarray, 20 were identified as 14-3-3 interactors, most of which were previously unreported 14-3-3-binding partners. However, 11 known 14-3-3-binding proteins, including keratin 18 (KRT18) and mitogen-activated protein kinase-activated protein kinase 2 (MAPKAPK2), were not identified as a 14-3-3-binding protein. The specific binding to 14-3-3 of EAP30 subunit of ELL complex (EAP30), dead box polypeptide 54 (DDX54), and src homology three (SH3) and cysteine rich domain (STAC) was verified by immunoprecipitation analysis of the recombinant proteins expressed in HEK293 cells. These results suggest that protein microarray is a powerful tool for rapid and comprehensive profiling of 14-3-3-binding proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16260042     DOI: 10.1016/j.jneumeth.2005.09.015

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  18 in total

1.  Proteomic analysis of 14-3-3 zeta binding proteins in the mouse hippocampus.

Authors:  Maura Heverin; Gary P Brennan; Christian J Koehler; Achim Treumann; David C Henshall
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-06-23

2.  Allosteric regulators selectively prevent Ca2+-feedback of CaV and NaV channels.

Authors:  Jacqueline Niu; Ivy E Dick; Wanjun Yang; Moradeke A Bamgboye; David T Yue; Gordon Tomaselli; Takanari Inoue; Manu Ben-Johny
Journal:  Elife       Date:  2018-09-10       Impact factor: 8.140

3.  Conserved features of cancer cells define their sensitivity to HAMLET-induced death; c-Myc and glycolysis.

Authors:  P Storm; S Aits; M K Puthia; A Urbano; T Northen; S Powers; B Bowen; Y Chao; W Reindl; D Y Lee; N L Sullivan; J Zhang; M Trulsson; H Yang; J D Watson; C Svanborg
Journal:  Oncogene       Date:  2011-06-06       Impact factor: 9.867

4.  Clinical implication of 14-3-3 epsilon expression in gastric cancer.

Authors:  Mariana Ferreira Leal; Danielle Queiroz Calcagno; Sâmia Demachki; Paulo Pimentel Assumpção; Roger Chammas; Rommel Rodríguez Burbano; Marília de Arruda Cardoso Smith
Journal:  World J Gastroenterol       Date:  2012-04-07       Impact factor: 5.742

Review 5.  DEAD-box helicases: posttranslational regulation and function.

Authors:  Eric A Gustafson; Gary M Wessel
Journal:  Biochem Biophys Res Commun       Date:  2010-03-03       Impact factor: 3.575

6.  Targeting of nucleotide-binding proteins by HAMLET--a conserved tumor cell death mechanism.

Authors:  J C S Ho; A Nadeem; A Rydström; M Puthia; C Svanborg
Journal:  Oncogene       Date:  2015-06-01       Impact factor: 9.867

7.  Modulation of mitogen-activated protein kinase-activated protein kinase 3 by hepatitis C virus core protein.

Authors:  Huong T T Ngo; Long V Pham; Jong-Wook Kim; Yun-Sook Lim; Soon B Hwang
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

8.  Stac3 is required for myotube formation and myogenic differentiation in vertebrate skeletal muscle.

Authors:  Neil I Bower; Daniel Garcia de la Serrana; Nicholas J Cole; Georgina E Hollway; Hung-Tai Lee; Stephen Assinder; Ian A Johnston
Journal:  J Biol Chem       Date:  2012-10-17       Impact factor: 5.157

9.  Changes in proteasome structure and function caused by HAMLET in tumor cells.

Authors:  Lotta Gustafsson; Sonja Aits; Patrik Onnerfjord; Maria Trulsson; Petter Storm; Catharina Svanborg
Journal:  PLoS One       Date:  2009-04-14       Impact factor: 3.240

10.  Expanding the substantial interactome of NEMO using protein microarrays.

Authors:  Beau J Fenner; Michael Scannell; Jochen H M Prehn
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.